Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Hendarto H, Inoguchi T, Maeda Y, et al
As WADA's science advances and new performance-enhancing compounds emerge, the gap between basic certification and comprehensive testing continues to widen
Ro (formerly Roman), is an online telehealth platform launched in 2017 that gives patients access to two FDA-approved GLP-1 medications, Wegovy and Zepbound, as part of its weight-loss program, the Body Program
Key disclosures from company terms include: MEDVi states it does not directly provide medical or pharmacy services Payment does not guarantee the writing or dispensing of a prescription The site identifies itself as "an advertisement for services and not any specific medication" OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s to patients Entity Structure According to MEDVi's terms of use: "MEDVi does not provide any Healthcare Services through the Platform and is not licensed to practice medicine." MEDVi, LLC: Technology platform providing intake coordination, customer service, and payment processing OpenLoop Health: According to company disclosures, provides the network of licensed medical providers who conduct evaluations and make prescribing decisions Partner compounding pharmacies: According to the website, MEDVi partners with "multiple USA certified pharmacies" Pricing (As of December 26, 2025) Cost considerations are separate from medical appropriateness and should not influence prescribing decisions
.jpg)